Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-13

Clinical Trial Update: Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression? [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update from NIMH on whether enhancing glutamate transporter function can produce antidepressant effects in adults with major depressi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Depression | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-10-13